Screening for Elevated Blood Lead Levels

• Published in: Pediatrics (Evanston) 1998-06, Vol.101 (6), p.1072-1078
• Main Authors: Etzel, Ruth A, Balk, Sophie J, Bearer, Cynthia F, Miller, Mark D
• Format: Article
• Language: English
• Subjects: Biological and medical sciences; Blood; Chemical and industrial products toxicology. Toxic occupational diseases; Lead; Medical sciences; Medical screening; Metals and various inorganic compounds; Pediatrics; Toxicology
• ISSN: 0031-4005; 1098-4275
• DOI: 10.1542/peds.101.6.1072

Although recent data continue to demonstrate a decline in the prevalence of elevated blood lead levels (BLLs) in children, lead remains a common, preventable, environmental health threat. Because recent epidemiologic data have shown that lead exposure is still common in certain communities in the United States, the Centers for Disease Control and Prevention recently issued new guidelines endorsing universal screening in areas with ≥27% of housing built before 1950 and in populations in which the percentage of 1- and 2-year-olds with elevated BLLs is ≥12%. For children living in other areas, the Centers for Disease Control and Prevention recommends targeted screening based on risk-assessment during specified pediatric visits. In this statement, The American Academy of Pediatrics supports these new guidelines and provides an update on screening for elevated BLLs. The American Academy of Pediatrics recommends that pediatricians continue to provide anticipatory guidance to parents in an effort to prevent lead exposure (primary prevention). Additionally, pediatricians should increase their efforts to screen children at risk for lead exposure to find those with elevated BLLs (secondary prevention).